(Q48874224)

16 February 2018

editorial

0 references

title

Treatment advances for glioblastoma. (English)

1 reference

16 February 2018

author

Nise Yamaguchi

series ordinal

2

1 reference

16 February 2018

author name string

Eric T Wong

series ordinal

1

1 reference

16 February 2018

publication date

1 October 2011

1 reference

16 February 2018

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

published in

1 reference

16 February 2018

volume

11

1 reference

16 February 2018

issue

10

1 reference

16 February 2018

page(s)

1343-1345

1 reference

16 February 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Bevacizumab for recurrent glioblastoma multiforme: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Bevacizumab salvage therapy following progression in high-grade glioma patients treated with VEGF receptor tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

The cerebrospinal fluid provides a proliferative niche for neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

Cancer vaccines in glioma: how to balance the challenges of small trials, efficiency, and potential adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.127

21 January 2018

Identifiers

DOI

10.1586/ERN.11.127

1 reference

16 February 2018

1 reference

16 February 2018